advertisement
Abstract #82602 Published in IGR 20-4
Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area
Zhou K; Shang X; Wang XY; Wang XJ; Cheng HH; Hu HS; Huang QJ; Pan XF; Xu X; Liang YBChinese Journal of Ophthalmology 2019; 55: 777-784
To evaluate risk factors for visual field (VF) loss progression in primary open-angle glaucoma patients. A prospective nested case-control study. Patients were collected from the Wenzhou glaucoma progression study in the Eye Hospital of Wenzhou Medical University during March 2014 and April 2018. In this study, the eyes were divided into a progression group and a non-progression group using the glaucoma progression analysis methods to analyze the risk factors for glaucomatous VF loss progression. Axial length (AL) and central corneal thickness (CCT) were measured using the Lenstar LS900. The baseline, fluctuation (standard deviation), mean, maximum, minimum and range of intraocular pressure (IOP) during the follow-up period were determined based on IOP measured at each follow-up. The IOP measurements were included from the baseline to the last visit (for the non-progression group), or to the visit at which VF loss progression was determined (for the progression group). The independent sample -test, Mann-Whitney inspection and Cox proportional hazards models were used for statistical analysis. A total of 140 patients (140 eyes) were enrolled, including 67 males and 73 females. There were 19.3% of the eyes (27 of 140 eyes) showing VF loss progression. The median time to the endpoint for progression was 24.0 (16.0, 40.0) months. The AL in the progression group and non-progression group were 23.58 (23.05, 24.24) mm and 23.91 (23.10, 24.91) mm (0.111). The CCT in the two groups were 531.0 (512.0, 565.0) μm and 535.0 (518.5, 552.0) μm, respectively (0.897). The baseline age in the progression group and non-progression group was 71.0 (68.0, 74.0) years and 68.0 (58.0, 72.0) years, respectively (-2.872, 0.004). The slope of visual field index in the two groups was -3.50 (-7.10, -1.80)%/year and 0.40 (-0.60, 1.40)%/year, respectively (-6.823, 0.01). The mean IOP during the follow-up was (16.2±2.7) mmHg (1 mmHg=0.133 kPa) in the progression group and (15.1±2.4) mmHg in the non-progression group (-2.215, 0.028). The IOP fluctuation in the progression group and non-progression group was (2.6±1.3) mmHg and (2.0±0.7) mmHg, respectively (-2.175, 0.038). In the multivariate model, older baseline age (=1.080; 95:1.019-1.143), higher baseline IOP (=1.120; 95:1.016-1.236), higher mean IOP (=1.145; 95:1.001-1.309) and higher IOP fluctuation (=1.750; 95:1.193-2.566) were all significantly predictive risk factors for glaucomatous VF loss progression. Longer AL (=0.725; 95:0.532-0.988) was a protective factor against VF loss progression. However, CCT was found to be not associated with VF loss progression. Baseline age, baseline IOP, mean IOP, IOP fluctuation and shorter AL are found to be risk factors for glaucomatous VF loss progression among eyes with primary open-angle glaucoma in Wenzhou.
The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou 325000, China.
Full articleClassification:
6.20 Progression (Part of: 6 Clinical examination methods)
